Security key
44486Q111
- Security type / class
- Equity / *W EXP 08/27/202
- Total 13F shares
- 533,939
- Total 13F value
- $958,009
- Share change
- -367,058
- SEC-reported price per share
- $1.80
- Number of holders
- 7
- Value change
- -$590,063
- Number of buys
- 2
- Number of sells
- 7
Report period
Q3 2024
Institutions
7
Top holders
7
HUMAW full security history
Ownership snapshot
Full 13F holder table
Humacyte, Inc. SEC filings
Humacyte, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of HUMAW - Humacyte, Inc. - *W EXP 08/27/202 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Ayabudge LLC
Disclosed value leader
BlackRock Finance, Inc.
Comparable rows
0/15
Latest evidence
30 Jun 2024
3/4/5
13F
Highest disclosed value: $34,272,068
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock Finance, Inc. has the largest disclosed position value at $34.27M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Finance, Inc.'s linked filing trail.
Disclosed position value
Top 5
Ayabudge LLC
$9.75M
BlackRock Finance, Inc.
$34.27M
VANGUARD GROUP INC
$22.7M
FRESENIUS MEDICAL CARE HOLDINGS I...
$21.79M
STATE STREET CORP
$13.77M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Ayabudge LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$9,747,457
8,191,140 shares
|
— | 17 Aug 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$34,272,068
7,140,014 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$22,702,051
4,729,594 shares
|
— | 30 Jun 2024 |
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ |
3/4/5
Former 10% Shareholder
|
—
denominator unverified
|
$21,792,154
18,312,735 shares
|
— | 26 Aug 2021 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$13,769,405
2,868,626 shares
|
— | 30 Jun 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$8,934,853
1,861,098 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
7
Shares
533,939
Rows available
7
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
10
Q3 2024 holders
7
Holder diff
-3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|